CDKN1C antibody (AA 200-316)
Quick Overview for CDKN1C antibody (AA 200-316) (ABIN8120826)
Target
See all CDKN1C AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 200-316
-
Purpose
- p57kip2 Rabbit mAb
-
Specificity
- This antibody detects endogenous levels of p57kip2 (ABT76R) rabbit mAb protein.
-
Purification
- The antibody was purified by protein A affinity chromatography.
-
Immunogen
- A synthetic peptide corresponding to the amino acid region 200 - 316 of the human p57kip2.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB, 1:500-1:2000 | IHC, 1:50-1:200 | ELISA, Recommended starting concentration is 1 μg/mL. Please optimize the concentration based on your specific assay requirements.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- The antibody is provided in liquid form in phosphate - buffered saline with 50 % glycerol, 0.05 % BSA, and 0.05 % Proclin 300.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid freeze / thaw cycles
-
Storage
- -20 °C
-
Storage Comment
- Store at-20°C. Avoid freeze / thaw cycles.
-
-
- CDKN1C (Cyclin-Dependent Kinase Inhibitor 1C (p57, Kip2) (CDKN1C))
-
Alternative Name
- p57kip2
-
Background
-
Synonyms: CDKN1C, KIP2, Cyclin-dependent kinase inhibitor 1C, Cyclin-dependent kinase inhibitor p57, p57Kip2
Background: This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
Gene Name: CDKN1C
Protein Name: p57kip2 (ABT76R) rabbit mAb
-
Gene ID
- 1028
-
UniProt
- P49918
-
Pathways
- Cell Division Cycle, Dopaminergic Neurogenesis
Target
-